Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level
Establishes the population-level predictive validity of the Framingham Heart Study risk equation used to derive cardiovascular disease risk-prediction charts for NZ management guidelines on raised blood pressure and dyslipidaemia. Measures standard cardiovascular risk factors in a cohort of 6354 peo...
Saved in:
Published in | New Zealand medical journal Vol. 116; no. 1185; p. 9p |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Auckland
Pasifika Medical Association Group (PMAG)
07.11.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Establishes the population-level predictive validity of the Framingham Heart Study risk equation used to derive cardiovascular disease risk-prediction charts for NZ management guidelines on raised blood pressure and dyslipidaemia. Measures standard cardiovascular risk factors in a cohort of 6354 people (4638 men and 1716 women) aged 35-74 years with no history of cardiovascular disease, during 1992-3. Predicts cardiovascular event rates for the cohort using a Framingham risk equation and compares them with observed 5-year cardiovascular event rates for hospitalisation and mortality. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence. |
---|---|
Bibliography: | Archived by the National Library of New Zealand Figs; refs; tables; related article 'Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors', 7 Nov 2003, 116(1185) |
ISSN: | 0028-8446 1175-8716 1175-8716 |